全球體外轉錄模板市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測
市場調查報告書
商品編碼
1305257

全球體外轉錄模板市場研究報告 - 行業分析、規模、佔有率、成長、趨勢及2023年至2030年預測

Global In-Vitro Transcription Templates Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: | 出版商: Value Market Research | 英文 241 Pages | 商品交期: 最快1-2個工作天內

價格

體外轉錄模板市場的全球需求預計將從2022年的XX百萬美元達到2030年的近XX百萬美元,2023-2030年的複合年成長率為XX%。

體外轉錄模板是體外轉錄過程中使用的分子,是在試管或其他實驗室環境中合成RNA的過程。體外轉錄模板通常是含有待合成RNA序列的DNA分子。在體外轉錄過程中,DNA模板與試管中的RNA聚合酶和其他成分混合。然後RNA聚合酶讀取DNA模板並合成互補RNA分子。然後RNA分子可被純化並用於基因表達研究或作為RNA干擾的工具。體外轉錄模板可通過多種技術合成,如化學合成或PCR擴增。

市場動態:

基於RNA的療法,如RNA干擾和信使RNA療法,因其治療多種疾病的潛力而越來越受歡迎。體外轉錄模板是生產RNA療法的關鍵部件,對這些療法日益成長的需求推動了市場的成長。 CRISPR-Cas9等基因編輯技術日益普及,推動了體外轉錄模板的需求。體外轉錄模板用於製備CRISPR-Cas9基因編輯所需的引導RNA分子。隨著生物技術行業研發投入的不斷增加,體外轉錄模板的需求也在不斷成長。研究人員將這些模板用於廣泛的應用,如基因表達研究和基於RNA的療法開發。體外轉錄模板合成和純化技術的進步推動了市場的成長。目前正在開發新的更高效的合成方法,從而能夠以更低的成本生產高品質的模板。學術機構、研究組織和生物技術公司之間的合作與夥伴關係推動了體外轉錄模板市場的成長。這些合作有助於開發體外轉錄模板的創新應用。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰了解行業結構,評估全球競爭吸引力。此外,這些工具還對體外轉錄模板全球市場的各個細分市場進行了全面評估。體外轉錄模板行業的成長和趨勢為本研究提供了整體方法。

市場細分:

體外轉錄模板市場報告的這一部分提供了國家和地區層面細分市場的詳細數據,從而幫助戰略家確定各自產品或服務的目標人群以及即將到來的機會。

按疾病分類

  • 癌症(實體瘤、結直腸癌、鼻咽癌、黑色素瘤、白血病、前列腺癌、其他)
  • 傳染病(流感、COVID-19、愛滋病、其他)
  • 生活方式疾病
  • 遺傳性疾病
  • 其他疾病

按治療方法分類

  • 疫苗類
  • 治療

按研究階段

  • 探索階段
  • 臨床

按最終用戶

  • 製藥和生物技術公司
  • CRO和CMO
  • 學術研究
  • 其他

區域分析

本節涵蓋區域前景,重點介紹北美、歐洲、亞太、拉丁美洲以及中東和非洲地區體外轉錄模板市場的當前和未來需求。此外,報告還重點分析了所有主要地區各個應用領域的需求、估計和預測。

  • 全球體外轉錄模板各地區市場佔有率(代表圖)
  • 全球體外轉錄模板市場佔有率

該研究報告還涵蓋了市場主要參與者的綜合概況以及全球競爭格局的深入分析。體外轉錄模板市場的主要參與者包括Thermo Fisher Scientific Inc.、Promega Corporation、Agilent Technologies Inc.、New England Biolabs、Takara Bio Inc.、Lucigen Corporation、Enzynomics Co.Ltd.、Enzo Life Sciences Inc.、Cytiva (Danaher)。這部分包括競爭格局的整體視圖,其中包括各種戰略發展,如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品上市和其他發展。

如果您有任何客製化要求,請聯繫我們。我們的研究團隊可以根據您的需求提供客製化報告。

目 錄

第一章:前言

  • 報告描述
    • 報告目標
    • 目標受眾
    • 獨特銷售主張(USP)和產品
  • 研究範圍
  • 研究方法
    • 市場調研流程
    • 市場調研方法

第二章:執行摘要

  • 市場亮點
  • 全球市場概況

第三章:體外轉錄模板-行業分析

  • 簡介- 市場動態
  • 市場驅動因素
  • 市場限制因素
  • 市場機會
  • 行業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按疾病分類的市場吸引力分析
    • 按治療方法的市場吸引力分析
    • 按研究階段的市場吸引力分析
    • 按最終用戶的市場吸引力分析
    • 市場吸引力分析:按地區

第四章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商列表
    • 主要原料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直接行銷
    • 間接行銷
    • 行銷管道發展趨勢

第五章:全球體外轉錄模板市場分析:按疾病分類

  • 疾病概述
  • 歷史和預測數據
  • 按疾病分析
  • 癌症(實體瘤、結直腸癌、NSCLC、黑色素瘤、白血病、前列腺癌、其他)
  • 傳染病(流感、COVID-19、愛滋病、其他)
  • 生活方式疾病
  • 遺傳性疾病
  • 其他

第六章:全球體外轉錄模板市場分析:按治療分類

  • 治療概述
  • 歷史和預測數據
  • 按治療方法分析
  • 疫苗類
  • 治療

第七章:全球體外轉錄模板市場分析:按研究階段分類

  • 研究階段概述
  • 歷史和預測數據
  • 按研究階段分析
  • 探索性
  • 臨床研究

第八章:全球體外轉錄模板市場分析:按最終用戶分類

  • 終端用戶概述
  • 歷史和預測數據
  • 按最終用戶分析
  • 製藥和生物技術公司
  • CRO和CMO
  • 學術研究機構
  • 其他

第九章:全球體外轉錄模板市場分析:按地理區域分類

  • 地區前景
  • 產品介紹
  • 北美銷售分析
    • 概述、歷史和預測數據銷售分析
    • 北美細分市場銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 歐洲銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測數據銷售分析
    • 亞太地區細分市場銷售分析
    • 亞太地區各國銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 中東及非洲地區銷售分析
    • 中東及非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第10章: 體外轉錄模板企業競爭格局分析

  • 體外轉錄模板市場競爭格局
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品發布
  • 其他發展

第十一章:公司概況

  • 公司佔有率分析
  • 市場集中率
  • Thermo Fisher Scientific Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Promega Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Agilent Technologies Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • New England Biolabs
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Takara Bio Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Lucigen Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Enzynomics Co. Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Enzo Life Sciences Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Cytiva (Danaher)
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展

注-在公司概況中,財務細節和近期發展視情況而定,如果是私營公司則可能不包括在內。

Product Code: VMR112110702

The global demand for In-Vitro Transcription Templates Market is presumed to reach the market size of nearly USD XX MN by 2030 from USD XX MN in 2022 with a CAGR of XX% under the study period 2023 - 2030.

In-vitro transcription templates are molecules used in the process of in-vitro transcription, which is the process of synthesizing RNA in a test tube or other laboratory setting. In-vitro transcription templates are typically DNA molecules that contain the sequence of the RNA that is to be synthesized. During in-vitro transcription, the DNA template is mixed with RNA polymerase enzymes and other components in a test tube. The RNA polymerase enzyme then reads the DNA template and synthesizes a complementary RNA molecule. The RNA molecule can then be purified and used for gene expression studies or as a tool for RNA interference. In-vitro transcription templates can be synthesized using a variety of techniques, such as chemical synthesis or PCR amplification.

Market Dynamics:

RNA-based therapies, such as RNA interference and messenger RNA therapeutics, are gaining popularity due to their potential to treat a variety of diseases. In-vitro transcription templates are a key component in the production of RNA-based therapies, and the growing demand for these therapies is driving the growth of the market. Gene editing technologies such as CRISPR-Cas9 are gaining popularity and are driving the demand for in-vitro transcription templates. In-vitro transcription templates are used in the preparation of guide RNA molecules, which are necessary for CRISPR-Cas9 gene editing. With the increasing investment in research and development in the biotechnology industry, the demand for in-vitro transcription templates is growing. Researchers are using these templates for a wide range of applications, such as gene expression studies and the development of RNA-based therapies. Advancements in the synthesis and purification of in-vitro transcription templates are driving the growth of the market. New and more efficient synthesis methods are being developed, allowing for the production of high-quality templates at lower costs. Collaborations and partnerships between academic institutions, research organizations, and biotech companies are driving the growth of the In-Vitro Transcription Templates market. These collaborations are allowing for the development of new and innovative applications for in-vitro transcription templates.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in-vitro transcription templates. The growth and trends of in-vitro transcription templates industry provide a holistic approach to this study.

Market Segmentation:

This section of the in-vitro transcription templates market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Disease

  • Cancer (Solid Tumors, Colorectal Cancer, Nsclc, Melanoma, Leukemia, Prostate Cancer, Others)
  • Infectious Diseases (Influenza, COVID-19, Aids, Others)
  • Lifestyle Diseases
  • Genetic Diseases
  • Others

By Treatment

  • Vaccine
  • Therapeutic

By Research Stage

  • Exploratory
  • Clinical

By End User

  • Pharmaceutical & Biotechnology Companies
  • CROs & CMOs
  • Academics & Research
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the In-Vitro Transcription Templates market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

  • Global In-Vitro Transcription Templates Market Share by Region (Representative Graph)
  • Global In-Vitro Transcription Templates Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the in-vitro transcription templates market include Thermo Fisher Scientific Inc., Promega Corporation, Agilent Technologies Inc., New England Biolabs, Takara Bio Inc., Lucigen Corporation, Enzynomics Co. Ltd., Enzo Life Sciences Inc., Cytiva (Danaher). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . IN-VITRO TRANSCRIPTION TEMPLATES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Disease
    • 3.7.2 Market Attractiveness Analysis By Treatment
    • 3.7.3 Market Attractiveness Analysis By Research Stage
    • 3.7.4 Market Attractiveness Analysis By End User
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET ANALYSIS BY DISEASE

  • 5.1 Overview by Disease
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Disease
  • 5.4 Cancer (Solid Tumors, Colorectal Cancer, NSCLC, Melanoma, Leukemia, Prostate Cancer, Others) Historic and Forecast Sales by Regions
  • 5.5 Infectious Diseases (Influenza, COVID-19, AIDS, Others) Historic and Forecast Sales by Regions
  • 5.6 Lifestyle Diseases Historic and Forecast Sales by Regions
  • 5.7 Genetic Diseases Historic and Forecast Sales by Regions
  • 5.8 Others Historic and Forecast Sales by Regions

6 . GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET ANALYSIS BY TREATMENT

  • 6.1 Overview by Treatment
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Treatment
  • 6.4 Vaccine Historic and Forecast Sales by Regions
  • 6.5 Therapeutic Historic and Forecast Sales by Regions

7 . GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET ANALYSIS BY RESEARCH STAGE

  • 7.1 Overview by Research Stage
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Research Stage
  • 7.4 Exploratory Historic and Forecast Sales by Regions
  • 7.5 Clinical Historic and Forecast Sales by Regions

8 . GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET ANALYSIS BY END USER

  • 8.1 Overview by End User
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End User
  • 8.4 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
  • 8.5 CROs & CMOs Historic and Forecast Sales by Regions
  • 8.6 Academics & Research Historic and Forecast Sales by Regions
  • 8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL IN-VITRO TRANSCRIPTION TEMPLATES MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE IN-VITRO TRANSCRIPTION TEMPLATES COMPANIES

  • 10.1. In-Vitro Transcription Templates Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF IN-VITRO TRANSCRIPTION TEMPLATES INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Thermo Fisher Scientific Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Promega Corporation
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Agilent Technologies Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. New England Biolabs
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Takara Bio Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Lucigen Corporation
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Enzynomics Co. Ltd.
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Enzo Life Sciences Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Cytiva (Danaher)
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Disease (USD MN)
  • Cancer (Solid Tumors, Colorectal Cancer, NSCLC, Melanoma, Leukemia, Prostate Cancer, Others) Market Sales by Geography (USD MN)
  • Infectious Diseases (Influenza, COVID-19, AIDS, Others) Market Sales by Geography (USD MN)
  • Lifestyle Diseases Market Sales by Geography (USD MN)
  • Genetic Diseases Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Treatment (USD MN)
  • Vaccine Market Sales by Geography (USD MN)
  • Therapeutic Market Sales by Geography (USD MN)
  • Analysis by Research Stage (USD MN)
  • Exploratory Market Sales by Geography (USD MN)
  • Clinical Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
  • CROs & CMOs Market Sales by Geography (USD MN)
  • Academics & Research Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global In-Vitro Transcription Templates Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of In-Vitro Transcription Templates Report
  • Market Research Process
  • Market Research Methodology
  • Global In-Vitro Transcription Templates Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Disease
  • Market Attractiveness Analysis by Treatment
  • Market Attractiveness Analysis by Research Stage
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Disease (USD MN)
  • Cancer (Solid Tumors, Colorectal Cancer, NSCLC, Melanoma, Leukemia, Prostate Cancer, Others) Market Sales by Geography (USD MN)
  • Infectious Diseases (Influenza, COVID-19, AIDS, Others) Market Sales by Geography (USD MN)
  • Lifestyle Diseases Market Sales by Geography (USD MN)
  • Genetic Diseases Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Treatment (USD MN)
  • Vaccine Market Sales by Geography (USD MN)
  • Therapeutic Market Sales by Geography (USD MN)
  • Global Market Analysis by Research Stage (USD MN)
  • Exploratory Market Sales by Geography (USD MN)
  • Clinical Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
  • CROs & CMOs Market Sales by Geography (USD MN)
  • Academics & Research Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.